Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

carmustine with propylene glycol formulation VI-0609

An injectable ethanol-free formulation containing carmustine with propylene glycol, with antineoplastic activity. Upon administration, carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. The ethanol-free formulation of carmustine may lead to fewer toxicities than the ethanol-based formulation.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	carmustine ethanol-free formulation VI-0609 carmustine formulation VI-0609
Code name:	VI 0609 VI-0609 VI0609

carmustine with propylene glycol formulation VI-0609

Search NCI's Drug Dictionary